Outlook Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.42

-0.02 (-4.59%)

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 7 70%

Hold 3 30%

Sell 0 0%

Price Target

Analyst Price Target +8,182.9% upside

Low Target $27.07

Average Target $34.78

High Target $51.13

Current Price $0.42

Current
$0.42

Target
$34.78

$27.07 $34.78 avg $51.13

Scenario Analysis

Bear Case

$27.07

6,346.8%

Low target

Base Case

$34.78

+8,182.9%

Avg target

Bull Case

$51.13

+12,076.7%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$2.54

-83.5% from high

52-Week Low

$0.16

+160.6% from low

Target vs 52W High

$34.78

+1,270.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.5%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.5%
MRNA Moderna Inc	Hold	31	32%	$149.45	-35.4%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-91.9%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.7%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-35.3%